Search

Your search keyword '"Sanz, Guillermo F."' showing total 7 results
Start Over Author "Sanz, Guillermo F." Journal annals of hematology
7 results on '"Sanz, Guillermo F."'

1. Immune reconstitution after single-unit umbilical cord blood transplantation using anti-thymoglobulin and myeloablative conditioning in adults with hematological malignancies

Author

Cordón, Lourdes, Chorão, Pedro, Martín-Herreros, Beatriz, Montoro, Juan, Balaguer, Aitana, Guerreiro, Manuel, Villalba, Marta, Facal, Ana, Asensi, Pedro, Solves, Pilar, Gómez, Inés, Santiago, Marta, Lamas, Brais, Bataller, Ana, Granados, Pablo, Sempere, Amparo, Sanz, Guillermo F., Sanz, Miguel A., and Sanz, Jaime

Published
2024
Full Text
View/download PDF

2. Incidence and outcome of invasive fungal disease after front-line intensive chemotherapy in patients with acute myeloid leukemia: impact of antifungal prophylaxis

Author

Rodríguez-Veiga, Rebeca, Montesinos, Pau, Boluda, Blanca, Lorenzo, Ignacio, Martínez-Cuadrón, David, Salavert, Miguel, Pemán, Javier, Calvillo, Pilar, Cano, Isabel, Acuña, Evelyn, Villalba, Ana, Piñana, José Luis, Sanz, Jaime, Solves, Pilar, Senent, Leonor, Vicente, Ana, Sempere, Amparo, Cervera, José, Barragán, Eva, Jarque, Isidro, Torres, Antonio, Sanz, Miguel A., and Sanz, Guillermo F.

Published
2019
Full Text
View/download PDF

4. Simultaneous analysis of the expression of 14 genes with individual prognostic value in myelodysplastic syndrome patients at diagnosis: WT1 detection in peripheral blood adversely affects survival

Author

Santamaría, Carlos, Ramos, Fernando, Puig, Noemi, Barragán, Eva, de Paz, Raquel, Pedro, Carme, Insunza, Andrés, Tormo, Mar, del Cañizo, Consuelo, Diez-Campelo, María, Xicoy, Blanca, Salido, Eduardo, del Real, Javier Sánchez, Hernández, Montserrat, Chillón, Carmen, Sanz, Guillermo F., García-Sanz, Ramón, San Miguel, Jesús F., and González, Marcos

Published
2012
Full Text
View/download PDF

5. Prognostic value of cytogenetics in adult patients with Philadelphia-negative acute lymphoblastic leukemia

Author

Gómez-Seguí, Inés, Cervera, Jose, Such, Esperanza, Martínez-Cuadrón, David, Luna, Irene, Ibáñez, Mariam, López-Pavía, María, Gascón, Adriana, Roig, Mónica, Martínez, Jesús, Sanz, Jaime, Montesinos, Pau, Martín-Aragonés, Guillermo, Lorenzo, Ignacio, Senent, Leonor, Barragán, Eva, Cordón, Lourdes, Sempere, Amparo, Sanz, Guillermo F., and Sanz, Miguel Angel

Published
2012
Full Text
View/download PDF

6. Factors influencing platelet transfusion refractoriness in patients undergoing allogeneic hematopoietic stem cell transplantation.

Author

Solves, Pilar, Sanz, Jaime, Freiria, Carmen, Santiago, Marta, Villalba, Ana, Gómez, Inés, Montesinos, Pau, Montoro, Juan, Piñana, Jose Luis, Lorenzo, José Ignacio, Puig, Nieves, Sanz, Guillermo F, Sanz, Miguel Ángel, and Carpio, Nelly

Subjects
BLOOD platelet transfusion, HEMATOPOIETIC stem cell transplantation, HOMOGRAFTS, RETROSPECTIVE studies, ANTIBIOTICS, GRAFT rejection, SURVIVAL analysis (Biometry), TREATMENT effectiveness, HEMATOLOGIC malignancies, THERAPEUTICS
Abstract

Hematopoietic stem cell transplantation has been considered a risk factor for development of platelet transfusion refractoriness. The objective of this study was to assess the platelet transfusion refractoriness rate in patients undergoing allogeneic hematopoietic stem cell transplantation from different sources. We retrospectively reviewed the charts and transfusion records of patients who underwent allogeneic stem cell transplantation at our institution between 2013 and 2015. The evaluation of post-transfusion platelet count was assessed for each transfusion given, from day of progenitor infusion to day 30 after transplantation. Of 167 patients included in this study, 101 received peripheral blood stem cell transplantation (PBSCT) and 66 received umbilical cord blood transplantation (UCBT). Overall, the percentage of platelet transfusions with a 14-h CCI lower than 5000 was 59.3%, being these data significantly higher for UCBT (67.6%) than for PBSCT (31.0%). Seventy-eight percent of patients underwent UCBT become refractory, while 38.6% of patients who received PBSCT were refractory. Factors associated to platelet refractoriness were lower CD34+ cell dose infused, higher number of antibiotics used, presence of anti-HLA I antibodies, and reduced-intensity conditioning regimen. Platelet refractoriness is a frequent and complex adverse event and remains a therapeutic challenge in the management of patients undergoing HSCT. There is a higher rate of platelet refractoriness in patients who received UCBT as compared to patients who received PBSCT. [ABSTRACT FROM AUTHOR]

Published
2018
Full Text
View/download PDF

7. Prognostic value of cytogenetics in adult patients with Philadelphia-negative acute lymphoblastic leukemia

Author

Gómez-Seguí, Inés, primary, Cervera, Jose, additional, Such, Esperanza, additional, Martínez-Cuadrón, David, additional, Luna, Irene, additional, Ibáñez, Mariam, additional, López-Pavía, María, additional, Gascón, Adriana, additional, Roig, Mónica, additional, Martínez, Jesús, additional, Sanz, Jaime, additional, Montesinos, Pau, additional, Martín-Aragonés, Guillermo, additional, Lorenzo, Ignacio, additional, Senent, Leonor, additional, Barragán, Eva, additional, Cordón, Lourdes, additional, Sempere, Amparo, additional, Sanz, Guillermo F., additional, and Sanz, Miguel Angel, additional

Published
2011
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results